Old Web
English
Sign In
Acemap
>
authorDetail
>
Eileen McNulty
Eileen McNulty
Refractory
Medicine
Cancer research
Immunology
Interleukin-3 receptor
2
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase 1/2 Dose-Escalation and Dose-Expansion Study of the Safety and Efficacy of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Patients with Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL)/ Lymphoblastic Lymphoma (LBL)
2021
Blood
Armin Ghobadi
Ibrahim Aldoss
Frederick L. Locke
Ryan J. Mattison
Deepa Bhojwani
Shannon L. Maude
Preeta Dasgupta
Karen Gheesling Mullis
Ayman Kabakibi
Alexander S. Hamil
Tom Leedom
Kenneth M. Chrobak
Eileen McNulty
Jan K. Davidson-Moncada
Matthew L. Cooper
John F. DiPersio
Show All
Source
Cite
Save
Citations (0)
A Phase 1 Study of Flotetuzumab, a CD123 x CD3 DART® Protein, Combined with MGA012, an Anti-PD-1 Antibody, in Patients with Relapsed or Refractory Acute Myeloid Leukemia
2019
Blood
Andrew Wei
Chun Yew Fong
Pau Montesinos
María Calbacho
Jordi Sierra Gil
Jaime Pérez de Oteyza
Jacob M. Rowe
Ofir Wolach
Yishai Ofran
Yakir Moshe
Jichao Sun
Jan Baughman
Eileen McNulty
Ezio Bonvini
Jon M. Wigginton
Jan K. Davidson-Moncada
Show All
Source
Cite
Save
Citations (8)
1